Moreover, while our integrative analyses identified SPP1- and MAP1B-related pathways as potentially central to GBM biology, mechanistic dissection through animal models and molecular experiments will be critical to fully elucidate their roles. The gene discussed is MAP1B; the disease is glioblastoma.